163 related articles for article (PubMed ID: 7629641)
1. Relationship of local i.v. complications and the method of intermittenti.v. access.
Hunter ES; Bell E; Staub MA; Coyle G
J Intraven Nurs; 1995; 18(4):202-6. PubMed ID: 7629641
[TBL] [Abstract][Full Text] [Related]
2. Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agents.
Garrelts JC; Ast D; LaRocca J; Smith DF; Peterie JD
Clin Pharm; 1988 Oct; 7(10):760-5. PubMed ID: 3233896
[TBL] [Abstract][Full Text] [Related]
3. The impact of an i.v. team on the occurrence of intravenous-related phlebitis. A 30-month study.
Scalley RD; Van CS; Cochran RS
J Intraven Nurs; 1992; 15(2):100-9. PubMed ID: 1564603
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic complications in intravenous access.
Smith JP
J Intraven Nurs; 1998; 21(2):96-100. PubMed ID: 9601316
[TBL] [Abstract][Full Text] [Related]
5. Reducing infusion failure: a pharmacologic approach--a review.
Wright A
J Intraven Nurs; 1996; 19(2):89-97. PubMed ID: 8852169
[TBL] [Abstract][Full Text] [Related]
6. Preventing infection during i.v. therapy.
Wilson JA
Prof Nurse; 1994 Mar; 9(6):388-90, 392. PubMed ID: 8197214
[TBL] [Abstract][Full Text] [Related]
7. 9 common i.v. complications and what to do about them.
Bohony J
Am J Nurs; 1993 Oct; 93(10):45-9. PubMed ID: 8213945
[No Abstract] [Full Text] [Related]
8. Practical and professional aspects of i.v. therapy.
Scales K
Prof Nurse; 1997 May; 12(8 Suppl):S3-5. PubMed ID: 9180590
[TBL] [Abstract][Full Text] [Related]
9. Intravenous fluid therapy: a randomized controlled trial to investigate the effectiveness of the IV(2) flow medical device.
Fraser N; Snyman JR; Wessels F; Nel G
J Clin Nurs; 2007 Sep; 16(9):1593-601. PubMed ID: 17727580
[TBL] [Abstract][Full Text] [Related]
10. Monitoring i.v.-site infections.
Brannen S; Surette D
Can Nurse; 1997 Mar; 93(3):49-50. PubMed ID: 9110638
[TBL] [Abstract][Full Text] [Related]
11. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
Weber M; Meyer F; Halloul Z
Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
[TBL] [Abstract][Full Text] [Related]
12. [Infusion thrombophlebitis].
Nielsen JW; Christiansen CL; Andersen AO; Halkier P
Ugeskr Laeger; 1987 Jan; 149(2):81-3. PubMed ID: 3810974
[No Abstract] [Full Text] [Related]
13. Intravenous sites and fluids.
Huber D
Gastroenterol Nurs; 2008; 31(3):233-4. PubMed ID: 18542025
[No Abstract] [Full Text] [Related]
14. I.v.-related phlebitis, complications and length of hospital stay: 1.
Campbell L
Br J Nurs; 1998 Nov 26-Dec 9; 7(21):1304-6, 1308-12. PubMed ID: 10076204
[TBL] [Abstract][Full Text] [Related]
15. [Septic phlebitis: origin of severe septic condition].
Espinoza R; Andresen M; Nervi B; Rosemberg H
Rev Med Chil; 1998 Feb; 126(2):195-8. PubMed ID: 9659756
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral I.V. therapy and nursing].
Chen YC; Huang MC
Hu Li Za Zhi; 2006 Jun; 53(3):69-72. PubMed ID: 16767625
[TBL] [Abstract][Full Text] [Related]
17. A better way to chart i.v. therapy.
Newton GA
RN; 1988 Jul; 51(7):26-8. PubMed ID: 3387836
[No Abstract] [Full Text] [Related]
18. Documenting i.v. therapy, Part I.
Nursing; 2000 Feb; 30(2):73. PubMed ID: 11000847
[No Abstract] [Full Text] [Related]
19. Peripheral i.v. therapy (continuing education credit).
Lamb J
Nurs Stand; 1993 May 26-Jun 1; 7(36):31-6. PubMed ID: 8512866
[No Abstract] [Full Text] [Related]
20. Comparison of phlebitis rates with Buretrol and Harvard Mini-Infuser for administration of i.v. piggyback medications.
DeMonaco HJ; Cronin CM; Dempsey MJ; Tulley S
NITA; 1986; 9(6):475-7. PubMed ID: 3540733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
